Category: Press Release

BRISBANE, Australia,, July 13, 2023 (GLOBE NEWSWIRE) — Vytelle, a precision livestock company, is progressing on their five-year plan to provide accessible, hormone-free, bovine in vitro fertilisation to producers across the globe. Announced today, Vytelle has expanded to Brisbane, Australia with its sixteenth global laboratory.

Vytelle’s integrated technology platform combines Vytelle ADVANCE, a breakthrough in vitro fertilisation (IVF) technology, with Vytelle SENSE, an animal performance data capture system, and Vytelle INSIGHT, an artificial intelligence based genetic analytics engine.  The platform provides progressive cattle producers the technology to make reliable data-driven mating decisions that improve the predictability of genetic progress, replicating the right genetics faster.

The Brisbane-based, Australia laboratory brings accessibility to modern reproduction technology like never before to Australia’s eastern states’ beef herds. Vytelle’s hormone-free in vitro fertilisation process, including their proprietary media, will deliver high-quality embryos to producers allowing them to make more valuable calves, faster to maximise sustainability.

“Vytelle is the fastest growing bovine IVF company in the world,” commented Kerryann Kocher, CEO of Vytelle. She continued, “We are thrilled to open our doors in Brisbane, positioning Vytelle to serve 70% of the total beef herd in Australia from this location.”

 Vytelle has a long history in Australia through its Vytelle SENSE phenotypic data capture technology to measure and select for feed efficiency. With this investment, Vytelle is positioned to help Australian producers improve efficiencies and make faster genetic progress across the supply chain to consistently market more efficient and sustainable beef. “The large-scale adoption of IVF will be driven by the successful use of frozen embryos,” stated Andrew Donoghue, Regional Manager for Australia and New Zealand. He continued, “Unlike other technologies, the Vytelle system allows us to deliver frozen results producers can count on, providing reliable IVF to herds historically underserved with fresh programs.”

The Australian-based team is serving beef and dairy producers with on-farm ovum pick-ups immediately. Visit www.vytelle.com or contact Andrew Donoghue at andrew.donoghue@vytelle.com or +61 428 442 1555 to accelerate your herd’s genetic progress today.

Attachment

• Vytelle Expands to Brisbane, Australia

Andrew Donoghue
Vytelle
+61 428 442 1555
andrew.donoghue@vytelle.com

GlobeNewswire Distribution ID 8874359

Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster

SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced a $50 million investment by NVIDIA, which was executed as a private investment in public equity (PIPE). Recursion also announced plans to accelerate development of its AI foundation models for biology and chemistry, which, in collaboration with NVIDIA, it intends to optimize and distribute to biotechnology companies using NVIDIA cloud services.

“Our collaboration with NVIDIA represents two best-in-class companies coming together to help solve one of the world’s most difficult challenges, drug discovery,” said Chris Gibson, Ph.D., Co-founder and CEO of Recursion. “With our powerful dataset and NVIDIA’s accelerated computing capabilities, we intend to create groundbreaking foundation models in biology and chemistry at a scale unlike anything that has ever been released in the biological space.”

Recursion plans to utilize its vast proprietary biological and chemical dataset, which exceeds 23 petabytes and 3 trillion searchable gene and compound relationships, to accelerate the training of foundation models on NVIDIA DGX Cloud for possible commercial license/release on BioNeMo, NVIDIA’s cloud service for generative AI in drug discovery. NVIDIA will also help optimize and scale Recursion foundation models leveraging the NVIDIA AI stack and NVIDIA’s full-stack computing expertise. BioNeMo was announced earlier this year as a cloud service for generative AI in drug discovery, offering tools to quickly customize and deploy domain-specific, state-of-the-art biomolecular models at-scale through cloud APIs. Recursion anticipates using this software to support its internal pipeline as well as its current and future partners.

“Generative AI is a revolutionary tool to discover new medicines and treatments,” said Jensen Huang, founder and CEO of NVIDIA. “We are delighted to collaborate with Recursion’s world-class team, which is doing pioneering work in digital biology and chemistry with NVIDIA DGX and NVIDIA AI software to accelerate the development of the world’s largest biomolecular generative AI models and speed drug discovery for biotech and pharmaceutical companies.”

Recursion, through its recent acquisition of Valence Discovery, aims to accelerate the development of new technologies to feed the biopharma industry, while simultaneously democratizing access to large-scale models that have maximum impact in drug discovery.

About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montréal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on Twitter and LinkedIn.

Media Contact
Media@Recursion.com

Investor Contact
Investor@Recursion.com

Forward-Looking Statements
This document contains information that includes or is based upon “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, those regarding the acceleration and advancement of development of AI foundation models, as well as optimizing, licensing, and distributing such models; using BioNeMo software to support Recursion’s internal pipeline and well as Recursion’s current and future industry partners; Recursion accelerating development of new technologies through its Valence Discovery acquisition; and all other statements that are not historical facts. Forward-looking statements may or may not include identifying words such as “plan,” “will,” “expect,” “anticipate,” “intend,” “believe,” “potential,” “continue,” and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties such as those described under the heading “Risk Factors” in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K. All forward-looking statements are based on management’s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.

GlobeNewswire Distribution ID 8872969

QUEBEC CITY, July 12, 2023 (GLOBE NEWSWIRE) — LeddarTech^®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, is thrilled to announce the successful integration of LeddarTech’s advanced LeddarVision software with Ficosa’s cutting-edge surround-view camera system, along with other sensors such as radars, IMU and GPS. Ficosa is a leading global company dedicated to the research, development, production and marketing of advanced vision, safety and efficiency solutions for the automotive industry.

This significant milestone marks a major step forward in the strategic collaboration announced in December 2022 by Ficosa regarding integrating the LeddarVision software into Ficosa’s advanced driver assistance systems (ADAS) for parking. LeddarVision is a high-performance sensor fusion and perception software stack that provides extremely accurate 3D models of the vehicle’s surroundings, developed using raw data inputs from sensor systems. Integrating this software with Ficosa’s renowned vision technology unlocks the full potential of this software to enable Ficosa’s smart parking assistant for ADAS and AD.

In pursuit of their shared vision towards the consolidation of the autonomous vehicle, LeddarTech and Ficosa continue to strengthen their strategic collaboration towards developing a pioneering Intelligent Parking Assistance system, allowing even more detailed and precise perception of the surroundings. The hardware and software system architecture teams will begin equipping a car in Israel that will be used, in collaboration, to develop and demonstrate the smart parking assistance perception and driving features. Following this, two other vehicles in Europe will be added to the fleet showcasing the full software and hardware implementation for smart parking assist.

“LeddarTech is very pleased to partner in this collaboration and celebrate the success of integrating our LeddarVision software and Ficosa vision technology.” So stated Charles Boulanger, CEO of LeddarTech. “This relationship is driven by our commitment to pushing the boundaries of automotive technology by delivering cutting-edge solutions that enhance safety, efficiency and driver experiences. Our team is very excited to continue working with Ficosa on the next phase of the collaboration,” Mr. Boulanger concluded.

“At Ficosa, we strive to contribute to building a safer, more comfortable and efficient mobility of the future for everyone,” stated Josep Maria Forcadell, Chief Technology Officer at Ficosa. “In this sense, this innovative, intelligent automatic parking assistant that combines the fusion of LeddarTech’s low-level sensor and perception capabilities and Ficosa’s surround-view camera system will have a significantly positive impact, providing even more detailed and accurate perception of the environment,” Mr. Forcadell concluded.

About Ficosa

Ficosa is a leading global company dedicated to the research, development, production and marketing of advanced vision, safety and efficiency solutions for the automotive industry, with a vocation to contribute to society through its commitment to technological innovation, human values and energy efficiency. Founded in 1949 and with headquarters in Barcelona, Ficosa currently employs more than 8,500 people and has production and R&D centers and sales offices in Europe, North and South America, Asia and Africa. The Rear-View System (interior/side mirror) is Ficosa’s main, globally renowned business, which is recognized by the world’s leading original equipment manufacturers (OEMs). www.ficosa.com

Social media: Twitter @FICOSA_Int; LinkedIn Ficosa

For more information: Ficosa Communication Department
Mònica Acero: macero@llorenteycuenca.com +34 615 07 59 81
Pau Guerrero: pguerrero@llorenteycuenca.com

About LeddarTech

A global software company founded in 2007 and headquartered in Quebec City with additional R&D centers in Montreal, Toronto and Tel Aviv, Israel, LeddarTech develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. LeddarTech’s automotive-grade software applies advanced AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for better decision making and safer navigation. This high-performance, scalable, cost-effective technology is available to OEMs and Tier 1-2 suppliers to efficiently implement automotive and off-road vehicle ADAS solutions.

LeddarTech is responsible for several remote-sensing innovations, with over 150 patents granted or applied for that enhance ADAS and AD capabilities. Better awareness around the vehicle is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to seek to become the most widely adopted sensor fusion and perception software solution.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc. Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

• Investor relations website: https://investors.leddartech.com
• Investor relations contact: Kevin Hunt, ICR Inc. kevin.hunt@IcrInc.com
• Financial media contact: Dan Brennan, ICR Inc. dan.brennan@icrinc.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

GlobeNewswire Distribution ID 8871621